MedTrace Logo

Effectiveness of a Mobile Application in Improving Employees' Social Well-being.

NCT06495801 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1012

Last updated 2025-05-02

No results posted yet for this study

Summary

The goal of this cluster randomized controlled trial is to learn if using Frendie PRO mobile application at workplaces improves social well-being in employees. The main questions it aims to answer are:

Does using Frendie PRO mobile application at work for 6 months reduce loneliness in employees? Does using Fendie PRO mobile application at work for 6 months reduce social isolation in employees?

Researchers will compare employees from workplaces that use the Frendie PRO mobile application to employees from workplaces that do not use the mobile application to see if there are differences in their levels of social well-being (loneliness, social isolation, perceived social support, depressive symptoms).

Participants will be given access to the Frendie PRO mobile application and encouraged to use it by employers.

Conditions

  • Loneliness
  • Social Isolation
  • Social Support
  • Depressive Symptoms

Interventions

BEHAVIORAL

Frendie PRO mobile application

Frendie PRO mobile application offers employees an environment to manage their social relationships, organize leisure activities, and discuss personal or work-related matters.

Sponsors & Collaborators

  • Finnish Work Environment Fund

    collaborator OTHER

  • University of Eastern Finland

    lead OTHER

Principal Investigators

  • Siiri-Liisi Kraav, PhD · University of Eastern Finland

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
16 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-20
Primary Completion
2025-05-20
Completion
2025-08-01

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06495801 on ClinicalTrials.gov